ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Allegations Reflect Misunderstanding, Pan Data Says

August 4, 1989

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

DePinho Seeks Broad Waiver From COI Policy To Cover Financial Ties With 12 Entities

September 21, 2012

Administration Plans to Stop Paying Advisors; NIH, HHS to Make Protest

May 6, 1983

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000

Last Issue Until Aug. 20

July 30, 1982